Creative Planning Portfolio holdings
AUM
$117B
1-Year Return
13.67%
This Quarter Return
+8.7%
1 Year Return
+13.67%
3 Year Return
+45.97%
5 Year Return
+68.1%
10 Year Return
+115.56%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.63B
Cap. Flow
% of AUM
2.25%
Top 10 Holdings %
Top 10 Hldgs %
45.32%
Holding
3,738
New
314
Increased
1,944
Reduced
1,219
Closed
143
Top Buys
| 1 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$527M |
| 2 |
Vanguard Total Bond Market
BND
|
+$466M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$313M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$306M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$247M |
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$358M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$136M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$89.1M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.6M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$76.8M |
Sector Composition
| 1 | Technology | 7.02% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EOT
3226
Eaton Vance National Municipal Opportunities Trust
EOT
$259M
| $193K | ﹤0.01% |
11,882
| – | – |
|
3227
Treace Medical Concepts
TMCI
$467M
| $193K | ﹤0.01% |
32,809
-6,132
| -16% | -$36.1K |
|
3228
Viasat
VSAT
$4.14B
| $191K | ﹤0.01% |
13,103
+2,212
| +20% | +$32.3K |
|
3229
Vir Biotechnology
VIR
$728M
| $190K | ﹤0.01% |
37,759
+25,760
| +215% | +$130K |
|
|
OPRA
3230
Opera Ltd
OPRA
$1.75B
| $189K | ﹤0.01% |
+10,021
| New | +$189K |
|
3231
Cytek Biosciences
CTKB
$500M
| $189K | ﹤0.01% |
55,677
+45,652
| +455% | +$155K |
|
3232
Evolv Technologies
EVLV
$1.44B
| $189K | ﹤0.01% |
+30,298
| New | +$189K |
|
3233
OppFi
OPFI
$296M
| $188K | ﹤0.01% |
+13,418
| New | +$188K |
|
3234
Calamos Strategic Total Return Fund
CSQ
$3.01B
| $187K | ﹤0.01% |
+10,250
| New | +$187K |
|
3235
Nurix Therapeutics
NRIX
$703M
| $187K | ﹤0.01% |
+16,409
| New | +$187K |
|
|
PBT
3236
Permian Basin Royalty Trust
PBT
$846M
| $187K | ﹤0.01% |
14,995
+1,903
| +15% | +$23.7K |
|
3237
Ponce Financial Group
PDLB
$335M
| $186K | ﹤0.01% |
13,439
-103
| -0.8% | -$1.43K |
|
|
ORC
3238
Orchid Island Capital
ORC
$959M
| $185K | ﹤0.01% |
26,455
-14,307
| -35% | -$100K |
|
3239
Herbalife
HLF
$977M
| $185K | ﹤0.01% |
21,480
-1,966
| -8% | -$16.9K |
|
3240
Liberty Energy
LBRT
$1.62B
| $185K | ﹤0.01% |
16,095
-5,207
| -24% | -$59.8K |
|
3241
Greystone Housing Impact Investors LP
GHI
$254M
| $185K | ﹤0.01% |
16,311
+31
| +0.2% | +$351 |
|
3242
MidCap Financial Investment
MFIC
$1.16B
| $183K | ﹤0.01% |
14,539
+773
| +6% | +$9.76K |
|
3243
Recursion Pharmaceuticals
RXRX
$2.05B
| $183K | ﹤0.01% |
36,220
-1,869
| -5% | -$9.46K |
|
3244
Nuveen Municipal High Income Opportunity Fund
NMZ
$1.19B
| $182K | ﹤0.01% |
17,546
| – | – |
|
3245
Golub Capital BDC
GBDC
$3.91B
| $181K | ﹤0.01% |
12,375
-65,563
| -84% | -$960K |
|
3246
Kayne Anderson Energy Infrastructure Fund
KYN
$2.07B
| $181K | ﹤0.01% |
14,227
-1,255
| -8% | -$16K |
|
3247
Royce Value Trust
RVT
$1.95B
| $181K | ﹤0.01% |
12,006
+5
| +0% | +$75 |
|
3248
Titan International
TWI
$534M
| $181K | ﹤0.01% |
17,577
-24,670
| -58% | -$253K |
|
3249
Myriad Genetics
MYGN
$649M
| $180K | ﹤0.01% |
33,923
+9,804
| +41% | +$52.1K |
|
|
PKST
3250
Peakstone Realty Trust
PKST
$493M
| $180K | ﹤0.01% |
13,615
-5,131
| -27% | -$67.8K |
|